202 related articles for article (PubMed ID: 23026136)
1. E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation.
Zhi X; Zhao D; Wang Z; Zhou Z; Wang C; Chen W; Liu R; Chen C
Cancer Res; 2013 Jan; 73(1):385-94. PubMed ID: 23026136
[TBL] [Abstract][Full Text] [Related]
2. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.
Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C
Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428
[TBL] [Abstract][Full Text] [Related]
3. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
[TBL] [Abstract][Full Text] [Related]
4. E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer.
Wang L; Wang X; Zhao Y; Niu W; Ma G; Yin W; Shi C
Cancer Med; 2016 Aug; 5(8):2043-7. PubMed ID: 27227488
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
Smith CJ; Berry DM; McGlade CJ
J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
[TBL] [Abstract][Full Text] [Related]
6. The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.
Biswas K; Sarkar S; Du K; Brautigan DL; Abbas T; Larner JM
Mol Cancer Res; 2017 Jun; 15(6):651-659. PubMed ID: 28232384
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
8. Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.
Zhang Y; Liu Y; Duan J; Yan H; Zhang J; Zhang H; Fan Q; Luo F; Yan G; Qiao K; Liu J
Hepatology; 2016 Mar; 63(3):880-97. PubMed ID: 26659654
[TBL] [Abstract][Full Text] [Related]
9. RNF126 as a Marker of Prognosis and Proliferation of Gastric Cancer.
Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
Anticancer Res; 2020 Mar; 40(3):1367-1374. PubMed ID: 32132033
[TBL] [Abstract][Full Text] [Related]
10. E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.
Benini M; Fortuni S; Condò I; Alfedi G; Malisan F; Toschi N; Serio D; Massaro DS; Arcuri G; Testi R; Rufini A
Cell Rep; 2017 Feb; 18(8):2007-2017. PubMed ID: 28228265
[TBL] [Abstract][Full Text] [Related]
11. Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of ATR inhibitors.
Pan Y; Yang Y; Huang R; Yang H; Huang Q; Ji Y; Dai J; Qiao K; Tang W; Xie L; Yin M; Ouyang J; Ning S; Su D
Breast Cancer Res; 2022 Dec; 24(1):92. PubMed ID: 36539893
[TBL] [Abstract][Full Text] [Related]
12. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
[No Abstract] [Full Text] [Related]
13. CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells.
Wu W; Zhao J; Xiao J; Wu W; Xie L; Xie X; Yang C; Yin D; Hu K
Biochem Biophys Res Commun; 2021 Oct; 573():62-68. PubMed ID: 34388456
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase RNF126 regulates the retrograde sorting of the cation-independent mannose 6-phosphate receptor.
Smith CJ; McGlade CJ
Exp Cell Res; 2014 Jan; 320(2):219-32. PubMed ID: 24275455
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation.
Wang S; Wang T; Wang L; Zhong L; Li K
Onco Targets Ther; 2020; 13():10917-10929. PubMed ID: 33149608
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursolic acid on MAPK in cyclin D1 signaling and RING-type E3 ligase (SCF E3s) in two endometrial cancer cell lines.
Achiwa Y; Hasegawa K; Udagawa Y
Nutr Cancer; 2013; 65(7):1026-33. PubMed ID: 24083669
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
18. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
19. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy.
Zhang R; Liu W; Sun J; Kong Y; Chen C
Pharmacol Res; 2020 May; 155():104748. PubMed ID: 32147403
[TBL] [Abstract][Full Text] [Related]
20. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.
Wang Y; Deng O; Feng Z; Du Z; Xiong X; Lai J; Yang X; Xu M; Wang H; Taylor D; Yan C; Chen C; Difeo A; Ma Z; Zhang J
Oncogene; 2016 Mar; 35(11):1363-72. PubMed ID: 26234677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
